Homburger advised Credit Suisse in connection with PolyPeptide's EUR 111 m revolving credit facility agreement

On October 2, 2023, PolyPeptide announced the signing of a EUR 111 m three-year revolving credit facility with an uncommitted increase option of EUR 40 m, with Credit Suisse as the coordinator and agent, and, together with Danske Bank and Zürcher Kantonalbank as each as mandated lead arranger. The revolving credit facility allows PolyPeptide to refinance its existing borrowings from banks as well as finance its working capital and capital expenditure requirements to support its planned business growth.

Homburger advised Credit Suisse and the other banks with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Stefan Oesterhelt (Tax) as well as Nathalie Scherrer (Financing and Investment Products).